Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-EN Version v4-EN
Language English English
Date Updated 2023-07-18 2023-07-17
Drug Identification Number 02242325 02242325
Brand name AMIODARONE HYDROCHLORIDE FOR INJECTION AMIODARONE HYDROCHLORIDE FOR INJECTION
Common or Proper name AMIODARONE HCL AMIODARONE HCL
Company Name SANDOZ CANADA INCORPORATED SANDOZ CANADA INCORPORATED
Ingredients AMIODARONE HYDROCHLORIDE AMIODARONE HYDROCHLORIDE
Strength(s) 50MG 50MG
Dosage form(s) LIQUID LIQUID
Route of administration INTRAVENOUS INTRAVENOUS INTRAVENOUS INTRAVENOUS
Packaging size 3ml 10LIVI 3ml 10LIVI
ATC code C01BD C01BD
ATC description ANTIARRHYTHMICS, CLASS I AND III ANTIARRHYTHMICS, CLASS I AND III
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2023-07-10 2023-07-10
Estimated end date 2023-07-14 2023-07-14
Actual end date 2023-07-17 2023-07-17
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments